CEP-37250

CEP-37250 · Kyowa Kirin Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CEP-37250, covering 2024-04-29 to 2024-04-29. Get the full timeline:

Most recent: Clinical Trial Update: Phase 1 Study of CEP-37250/KHK2804 in Subjects With Advanced Solid Tumors [Phase 1]